Figure 23

![Figure 23: Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.]()

> Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." *Pharmaceuticals (Basel, Switzerland)*, 2023. PMID: [37631065](https://pubmed.ncbi.nlm.nih.gov/37631065/)

<figure>
  <img src="" alt="Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation." />
  <figcaption>Figure 23. Comparative analysis of antioxidant compounds evaluated for IBD treatment, illustrating differences in their molecular targets, bioavailability, or efficacy in reducing intestinal inflammation.<br>  Source: Alexander V Blagov et al. "Potential Use of Antioxidant Compounds for the Treatment of Inflammatory Bowel D." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2023. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37631065/">37631065</a></figcaption>
</figure>